Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

MONDAY, Feb. 6, 2023 (HealthDay News) -- The Functional Assessment of Cancer Therapy-Radionuclide Therapy (FACT-RNT) patient-reported outcome (PRO) tool has been developed for measuring symptoms/toxicities among prostate cancer (PC) patients receiving RNT, according to a report published online Jan. 12 in the Journal of Nuclear Medicine. Lisa Gudenkauf, Ph.D., from the Moffitt Cancer Center in

Related Keywords

Florida , United States , Tampa , Lisa Gudenkauf , Journal Of Nuclear Medicine , Moffitt Cancer Center , Healthday News , Functional Assessment , Cancer Therapy Radionuclide , Chronic Illness Therapy ,